[1]滕皋军.对比剂肾病:介入手术必须重视的并发症[J].介入放射学杂志,2008,(07):457.
 TENG Gaojun.Contrast induced nephropathy:an ignored important complication in interventional radiology[J].journal interventional radiology,2008,(07):457.
点击复制

对比剂肾病:介入手术必须重视的并发症()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2008年07期
页码:
457
栏目:
述评
出版日期:
2008-07-15

文章信息/Info

Title:
Contrast induced nephropathy:an ignored important complication in interventional radiology
作者:
滕皋军
210009南京东南大学附属中大医院放射科
Author(s):
TENG Gao-jun.
Department of Radiology,Zhongda Hospital,Southeast University,Nanjing210009,China
关键词:
对比剂肾病碘对比剂介入手术并发症
分类号:
R692
文献标志码:
C
摘要:
对比剂肾病(contrast induced nephropathy,CIN)已成为医院获得性肾病的第三大病因,在使用碘对比剂的人群中,尤其是存在肾功能不全的患者中发生率甚高。虽然该并发症的危害性已日益得到重视,但在影像与介入医师中尚未得到广泛的重视。本文就CIN的流行病学、定义、危险因素、临床预防与处理、预后等多方面进行了评述。并认为加强对该并发症的认识程度是影像与介入医师预防与处置CIN的关键。

参考文献/References:

[1]Waybill MM,Waybill PN.Contrast media-induced nephrotoxi-city:identification of patients at risk and algorithms for prevention[J].JVIR,2001,12:3-9.
[2]Gruberg L,Mintz GS,Mehran R,et al.The prognostic implications of further renal function deterioration within48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency[J].J Am Coll Cardiol,2000,36:1542-1548.
[3]Baker CS,Wragg A,Kmar S,et al.A rapid protocol for the prevention of contrast-induced renal dysfunction:RAPPD study[J].J Am Coll Cardiol,2003,41:2114-2118.
[4]Pannu N,Wiebe N.Prophylaxis strategies for contrast-induced nephropathy[J].JAMA,2006,295:2765-2779.
[5]Rao QA,Newhouse JH.Risk of nephropathy after intravenous administration of contrast material:a critical literature analysis[J].Radiology,2006,239:392-397.
[6]Barrett BJ ,Carlisle EJ.Meta analysis of the relative nephrotoxi-city of high-and low-osmolality iodinated contrast media[J].Radiology,1993,188:171-178.
[7]Rudnick MR,Goldfarb S,Wexler L,et al.Nephrotoxicity of ionic and nonionic contrast media in1196patients:a randomized trial[J].The Iohexol Cooperative Study.Kidney Int ,1995,47:254-261.
[8]Aspelin P,Aubry P,Fransson SG,et al.Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators[J].New Engl J Med,2003,348:491-499.
[9]倪靖炜,张瑞岩,张建盛,等.非离子型双体对比剂在冠状动脉介入治疗中应用的安全性观察[J].介入放射学杂志,2006,15:327-329.
[10]陈跃光,张大东,顾俊,等.冠状动脉介入治疗中非离子型对比剂对肾功能的影响和氯沙坦的保护价值[J].介入放射学杂志,2007,16:727-729.
[11]Marenzi G,Assanelli E.N-acetylcysteine and contrast-induced nephropathy in primary angioplasty[J].N Engl J Med,2006,354:2773-2782.
[12]Marenzi G,Marana I,Lauri G,et al.The prevention of radiocon-trast-agent-induced nephropathy by hemofiltration[J].N Engl J Med,2003,349:1333-1340.
[13]Solomon R,Deray G.Consensus Panel for CIN.How to prevent contrast-induced nephropathy and manage risk patients:practical recommendations[J].Kidney Int Suppl ,2006,100:S51-S53.

备注/Memo

备注/Memo:
收稿日期:2008-05-05
更新日期/Last Update: 2008-07-15